临床基因组研究中延迟入组所致选择偏倚的影响
真实世界数据中联合临床与基因组数据可能受左截断影响,即潜在研究参与者在招募时已超过关注里程碑而未被纳入。忽略左截断会高估总生存期,在IV期非小细胞肺癌或IV期结直肠癌患者中,未校正的中位生存期估计值被高估超过1年。应采用风险集校正方法分析此类数据。
要点
- 联合临床与基因组数据的真实世界数据集可能受左截断影响。
- 忽略左截断会高估总生存期,IV期非小细胞肺癌或结直肠癌中位生存期被高估超过1年。
- 应采用风险集校正方法分析此类数据以获取有效结果。
核心结论
- 临床基因组数据是评估真实世界癌症结局的宝贵资源,应使用适当方法分析以最大化其潜力。
- 分析人员必须熟练应用适当的统计方法,以确保研究结果有效、有意义且可推广。
研究设计与样本
- 本文为观察性方法学论述,使用美国癌症研究协会(AACR)项目GENIE BPC的数据说明忽略左截断的影响,并描述了一种直接的风险集校正方法。
- 研究对象为IV期非小细胞肺癌或IV期结直肠癌患者。
主要发现
- 忽略左截断导致总生存期被高估:从诊断时起算的未校正中位生存期估计值在IV期非小细胞肺癌或IV期结直肠癌患者中被高估超过1年。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Real-world data sets that combine clinical and genomic data may be subject to left truncation (when potential study participants are not included because they have already passed the milestone of interest at the time of study recruitment). The lapse between diagnosis and molecular testing can present analytic challenges and threaten the validity and interpretation of survival analyses. OBSERVATIONS: Effects of ignoring left truncation when estimating overall survival are illustrated using data from the American Association for Cancer Research (AACR) Project Genomics Evidence Neoplasia Information Exchange Biopharma Collaborative (GENIE BPC), and a straightforward risk-set adjustment approach is described. Ignoring left truncation results in overestimation of overall survival: unadjusted median survival estimates from diagnosis among patients with stage IV non-small cell lung cancer or stage IV colorectal cancer were overestimated by more than 1 year. CONCLUSIONS AND RELEVANCE: Clinicogenomic data are a valuable resource for evaluation of real-world cancer outcomes and should be analyzed using appropriate methods to maximize their potential. Analysts must become adept at application of appropriate statistical methods to ensure valid, meaningful, and generalizable research findings.
引用
- Brown S, Lavery JA, Shen R, et al. Implications of Selection Bias Due to Delayed Study Entry in Clinical Genomic Studies. JAMA Oncol. 2022. PMID: 34734967. doi:10.1001/jamaoncol.2021.5153
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。